LAWSON MACARTNEY

CIK 1606831 · last filed 2026-01-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.47M

Companies

2

Total Filings

17

Lifetime Open-Market Net

-$1.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
VKTX	Director	51,115	$28.75	$1.47M	-$1.29M	11	2026-01-05
Viking Therapeutics, Inc. (VKTXW) Delisted	Director	47,965	$4.60	$220.6K	$250.3K	6	2021-01-06

Recent Filings · Page 2 of 2

17 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2020-01-03	Viking Therapeutics, Inc. (VKTXW) Delisted	Grant (A)	—	$0	EDGAR
2019-01-03	Viking Therapeutics, Inc. (VKTXW) Delisted	Grant (A)	—	$0	EDGAR
2018-05-31	Viking Therapeutics, Inc. (VKTXW) Delisted	Buy (P)	+47,965	$250.3K	EDGAR
2018-01-03	Viking Therapeutics, Inc. (VKTXW) Delisted	Grant (A)	—	$0	EDGAR
2017-01-05	Viking Therapeutics, Inc. (VKTXW) Delisted	Grant (A)	—	$0	EDGAR
2016-01-06	VKTX	Grant (A)	—	$0	EDGAR
2015-04-30	VKTX	Grant (A)	—	$0	EDGAR

Showing 11–17 of 17

Prev Page 2 of 2

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.